136 related articles for article (PubMed ID: 12015205)
1. Evidence for an interaction between neuropeptide Y and the melanocortin-4 receptor on feeding in the rat.
Hansen MJ; Morris MJ
Neuropharmacology; 2002 May; 42(6):792-7. PubMed ID: 12015205
[TBL] [Abstract][Full Text] [Related]
2. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.
Kokare DM; Dandekar MP; Chopde CT; Subhedar N
Brain Res; 2005 May; 1043(1-2):107-14. PubMed ID: 15862523
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor.
Abbott CR; Rossi M; Kim M; AlAhmed SH; Taylor GM; Ghatei MA; Smith DM; Bloom SR
Brain Res; 2000 Jun; 869(1-2):203-10. PubMed ID: 10865075
[TBL] [Abstract][Full Text] [Related]
4. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.
Raposinho PD; Castillo E; d'Alleves V; Broqua P; Pralong FP; Aubert ML
Endocrinology; 2000 Dec; 141(12):4419-27. PubMed ID: 11108250
[TBL] [Abstract][Full Text] [Related]
5. The role of the melanocortin system and the melanocortin-4 receptor in ring dove (Streptopelia risoria) feeding behavior.
Strader AD; Schiöth HB; Buntin JD
Brain Res; 2003 Jan; 960(1-2):112-21. PubMed ID: 12505663
[TBL] [Abstract][Full Text] [Related]
6. Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats.
Vergoni AV; Bertolini A; Mutulis F; Wikberg JE; Schiöth HB
Eur J Pharmacol; 1998 Dec; 362(2-3):95-101. PubMed ID: 9874158
[TBL] [Abstract][Full Text] [Related]
7. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat.
Raposinho PD; White RB; Aubert ML
J Neuroendocrinol; 2003 Feb; 15(2):173-81. PubMed ID: 12535159
[TBL] [Abstract][Full Text] [Related]
8. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats.
Goyal SN; Kokare DM; Chopde CT; Subhedar NK
Pharmacol Biochem Behav; 2006 Oct; 85(2):369-77. PubMed ID: 17052748
[TBL] [Abstract][Full Text] [Related]
9. Central neuropeptide Y infusion and melanocortin 4 receptor antagonism inhibit thyrotropic function by divergent pathways.
Preston E; Cooney GJ; Wilks D; Baran K; Zhang L; Kraegen EW; Sainsbury A
Neuropeptides; 2011 Dec; 45(6):407-15. PubMed ID: 21862125
[TBL] [Abstract][Full Text] [Related]
10. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
Kask A; Schiöth HB; Harro J; Wikberg JE; Rägo L
Can J Physiol Pharmacol; 2000 Feb; 78(2):143-9. PubMed ID: 10737677
[TBL] [Abstract][Full Text] [Related]
11. Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y.
Kask A; Rägo L; Korrovits P; Wikberg JE; Schiöth HB
Biochem Biophys Res Commun; 1998 Jul; 248(2):245-9. PubMed ID: 9675121
[TBL] [Abstract][Full Text] [Related]
12. Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight.
Kask A; Rägo L; Wikberg JE; Schiöth HB
Eur J Pharmacol; 1998 Oct; 360(1):15-9. PubMed ID: 9845267
[TBL] [Abstract][Full Text] [Related]
13. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands.
Giraudo SQ; Billington CJ; Levine AS
Brain Res; 1998 Nov; 809(2):302-6. PubMed ID: 9853124
[TBL] [Abstract][Full Text] [Related]
14. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways.
Baran K; Preston E; Wilks D; Cooney GJ; Kraegen EW; Sainsbury A
Diabetes; 2002 Jan; 51(1):152-8. PubMed ID: 11756335
[TBL] [Abstract][Full Text] [Related]
15. Melanocortin mediated inhibition of feeding behavior in rats.
Murphy B; Nunes CN; Ronan JJ; Harper CM; Beall MJ; Hanaway M; Fairhurst AM; Van der Ploeg LH; MacIntyre DE; Mellin TN
Neuropeptides; 1998 Dec; 32(6):491-7. PubMed ID: 9920446
[TBL] [Abstract][Full Text] [Related]
16. Paraventricular hypothalamic alpha-melanocyte-stimulating hormone and MTII reduce feeding without causing aversive effects.
Wirth MM; Olszewski PK; Yu C; Levine AS; Giraudo SQ
Peptides; 2001 Jan; 22(1):129-34. PubMed ID: 11179607
[TBL] [Abstract][Full Text] [Related]
17. Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat.
Glavas MM; Joachim SE; Draper SJ; Smith MS; Grove KL
Endocrinology; 2007 Jul; 148(7):3279-87. PubMed ID: 17412803
[TBL] [Abstract][Full Text] [Related]
18. Interaction between alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses.
Lu XY; Barsh GS; Akil H; Watson SJ
J Neurosci; 2003 Aug; 23(21):7863-72. PubMed ID: 12944516
[TBL] [Abstract][Full Text] [Related]
19. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist.
Skuladottir GV; Jonsson L; Skarphedinsson JO; Mutulis F; Muceniece R; Raine A; Mutule I; Helgason J; Prusis P; Wikberg JE; Schiöth HB
Br J Pharmacol; 1999 Jan; 126(1):27-34. PubMed ID: 10051117
[TBL] [Abstract][Full Text] [Related]
20. Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus.
Tritos NA; Vicent D; Gillette J; Ludwig DS; Flier ES; Maratos-Flier E
Diabetes; 1998 Nov; 47(11):1687-92. PubMed ID: 9792536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
